Amniotic Fluid Lactate in Perterm Premature Rupture of Membranes

NCT03789903 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-12-31

No results posted yet for this study

Summary

AF lactate level could help in predicting the duration from ROM till delivery

Conditions

  • Rupture of Membranes; Premature

Interventions

DIAGNOSTIC_TEST

amniotic fluid lactate

AF lactate

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-01-01
Completion
2019-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03789903 on ClinicalTrials.gov